PreComb is developing new drug profiling solutions in precision medicine
For the patient
For the physician
Current cancer treatment guidelines are largely based on the therapeutic outcomes of entire patient populations, but predicting individual patient response based on genomics or biomarkers remains difficult.
Functional drug testing supports treatment decisions with personalized and real-time data to improve therapy success and patient quality of life.